chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Site: Bruising at Injection Site-Mild, Site: Itching at Injection Site-Mild, Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Systemic: Unable to Sleep-Medium, Systemic: Weakness-Medium, Additional Details: PATIENT CALLED TODAY TO SHARE POTENTIAL VACCINE ADVERSE EVENTS WITH COMPLAIN ABOUT REDNESS, INFLAMMATION, HOT TO TOUCH, AND SWELLING OF THE UPPER HAND. PATIENT'S CONSULT WAS PROVIDED TO APPLY ICE, USE TYLENOL FOR PAIN/DISCOMFORT AND TO BE IN TOUCH WITH DOCTOR/PHARMACY FOR ANY WORSENING SIGNS/SYMPTOMS. PATIENT IS MADE AWARE OF REGULAR FOLLOW UP WITH HER DR'S OFFICE AND TO HERSELF TO SEE HOW THINGS ARE PORGRESSING
Couldn't stand/Body did not respond; Could not control the body; Could not walk to bathroom; Felt tired; Sore arm; Night fever; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), FEELING ABNORMAL (Could not control the body), GAIT DISTURBANCE (Could not walk to bathroom), HYPOKINESIA (Couldn't stand/Body did not respond) and PYREXIA (Night fever) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included VITAMINS NOS for an unknown indication.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, the patient experienced PAIN IN EXTREMITY (Sore arm) and PYREXIA (Night fever). On 17-Mar-2021, the patient experienced FEELING ABNORMAL (Could not control the body), GAIT DISTURBANCE (Could not walk to bathroom) and FATIGUE (Felt tired). On an unknown date, the patient experienced HYPOKINESIA (Couldn't stand/Body did not respond). The patient was treated with PARACETAMOL (TYLENOL) for Fever, at an unspecified dose and frequency. On 17-Mar-2021, PAIN IN EXTREMITY (Sore arm), FEELING ABNORMAL (Could not control the body), GAIT DISTURBANCE (Could not walk to bathroom), PYREXIA (Night fever) and FATIGUE (Felt tired) had resolved. At the time of the report, HYPOKINESIA (Couldn't stand/Body did not respond) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications also include supplements.   Most recent FOLLOW-UP information incorporated above includes: On 08-Jul-2021: Follow up received on 08JUL2021, Added Reporter Email address and added NewEvent :Couldn't stand/Body did not respond.
Retracting whille breathing, too fast of heart rate and breathing too fast. Diagnosed with pneumonia.
Itching started 24-48 hours after the vaccination and was reported to VSafe and has continued til today.  My daily VSafe check ins have ended, so I'm reporting a new rash at the injection site.  Only today did I notice a round rash about 2 inches in diameter with a leading red edge, but I didn't look at the injection site for the last couple of days, so it may have been there before.
Onset vomiting, lethargy, black stools 3/31/12. Dx: Right upper quadrant intussusception. Tx: Reduction of the right upper quadrant intussusception.
Within ~ 2 hours post Fluzone vaccine, patient developed marked coughing, SOB, headache, and eventual bilateral conjunctivitis. Came back to clinic 4:40 pm (2 1/2 hours after onset cough) where BP elevated at 127/85, P92, resp 22-24, pulse OX 100%, and harsh expiratory breath sounds without wheezing. Given Benadryl 25 mg po, and 2 nebulizer treatments: one with Albuterol, other with Ipratropium and sent home on Prednisone.
Pt exp adverse reaction following vax w/Hep B; No further details were provided;
face was swollen; she had a feeling as if someone had given a bunch of shots of Novocain in her mouth; This is a spontaneous report from a contactable consumer (patient) received via medical information team. A 69-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date were not reported), via an unspecified route of administration on 09Mar2021 as dose 1, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced face was swollen, and she had a feeling as if someone had given a bunch of shots of Novocain in her mouth on 18Mar2021 02:00. Patient stated on 18Mar2021 at 2 am she woke up and her face was swollen. Patient stated she thought it might have been attributed what she had for dinner and the salt content that caused the swelling. Patient took 1 tablet of Benadryl and drank a bunch of water so that the medicine could circulate through her system and she went back to bed. Patient stated the swelling went down some. Patient had a feeling as if someone had given a bunch of shots of Novocain in her mouth. Her face felt puffy, but it wasn't the best that she could describe it. She took more Benadryl when woke up as well as it seemed to be helping. Patient would like to know if this was a normal reaction because it happened a week after her first dose was given. Patient would like to know what she should do about the swelling if it continues. Patient would also like to know if she should receive the second dose. Outcome of events was resolving.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Patient was given a dose of Vaxelis and a dose of ActHIB on the same day which is equivalent to a double dose of HIB. Doctor informed, parents informed, state immunization system informed, and an internal event reporting system completed. Manufacturer of vaccinations was notified. Per CDC it is not harmful to get a double dose of HIB.
Approximately one month after receiving vaccine, he had a left thalamic infact acute (CMS-HCC).  The was taken to Hospital immediately and was treated there.  Symptoms included right sided paralysis and weakness and slurred speech. Blood pressure was also elevated(184/97). Glucose(286).  Hospital stay was three days.
This spontaneous report as received from a pharmacy technician concerning a currently 42 years old patient. Gender was not reported. Medical history and concurrent conditions were not reported. On 17-APR-2014, the patient was vaccinated with VARIVAX (Merck) lot #J003700; expiration date: 27-MAR-2015, (dose, strength and route were not reported). Secondary and concomitant therapies were not reported. Patient was vaccinated with VARIVAX (Merck) that was exposed to 43.1 degrees F for 29 hours on 03-MAR-2014. This is one of several reports from the same reporter. Additional information has been requested.
This spontaneous report as received from a pharmacist concerning a patient of unknown age and gender. No concurrent condition, medical history or allergy/drug reactions were reported. On 27-JUN-2015, the patient was vaccinated with the first dose of GARDASIL injection (dose, route, anatomical location or lot# were unknown). Then, on 21-DEC-2015, the patient was vaccinated with the second dose of GARDASIL injection (dose, route, anatomical location or lot# were unknown). No concomitant medications were reported. No adverse experiences have been reported so far. There were no product quality complaints (PQC) involved. Additional information has been requested.
I got my second Covid-19 shot on April 8, 2021. I awoke on April 22, 2021 with a rapid heartbeat and was advised by my PCP to go to the ER. Testing in the ER showed that I had Graves' disease (hyperthyroid), and it caused atrial fibrillation. I had not had thyroid problems or atrial fibrillation before this.  Since then I have had two more episodes of atrial fibrillation, one of which led to an additional ER visit and 2-day hospital stay. I am currently seeing an endocrinologist and heart specialists to get both issues under control. Both have prescribed medications, but as of today the atrial fibrillation is not considered under control.
pt devel h/a, nausea & diarrhea w/in 4 hrs of the inject; sx gone by the following AM; no reaction p/dose #3; reaction just reported 5JAN93;
moderna booster shot site on left upper arm is very tender to the touch, throbbed and is raised and red for about the size of a silver dollar
Information has been received from a registered nurse concerning her son who on approximately 21-FEB-2008 was vaccinated with measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3). Concomitant therapy included AMOXIL. It was reported that the patient developed a rash from head to toe in approximately February 2008 from measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3). It was unknown if the patient sought medical attention. As of 06-MAR-2008, the patient had not recovered. No further information is available.This is one of several reports from the same source.
patient was given MenB vaccine instead of meningococcal ACYW. Patient is not on schedule for school vaccinations. patient's parents contacted.
Third dose of DAPTACEL injected into left thigh. Next day fever up to 101 rectally. Injection site got red (pink), swollen and indurated. Not tender. Next day, developed shaking in left hand and left leg, especially when reaching for something. Child always acted well in all other respects. Shaking lasted 3 days. Lump lasted 3 weeks. No residual symptoms are noted.
pain under her armpit where her lymph nodes are in the injection arm; radiated from where the shot was given up and around her armpit and it had been super painful; radiated from where the shot was given up and around her armpit and it had been super painful; This is a spontaneous report from a contactable consumer (patient's mother). A 13-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number and expiration date was not reported), dose 1 via an unspecified route of administration on 21Jun2021 as dose 1, single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient's mother stated her daughter received the Pfizer COVID vaccine on 21Jun2021 (on Monday evening of this week). The patient had been experiencing pain under her armpit where her lymph nodes were, in the injection arm (on Jun2021). It radiated from where the shot was given up and around her armpit and it had been super painful for her on 23Jun2021 (today). The reporter would like to know if this will subside or what should she do about it. The patient's mother stated since this was possibly due to a robust immune response, she had heard that the second dose would produce more side effects than the first. The patient's mother would like to know if this was true and should she expect the same type of reaction with the second dose. The patient's mother would like to know if her daughter should receive the second dose of the vaccine. The outcome for all events was not recovered. Information related to batch/Lot no. was requested.
About 1AM on 10OCT91 pt noted bad itch of chest - noted 10 bumps white center red around edge; bumps clearing when arrived @ clinic; pt states felt nauseated 1.5 hrs p/immun; P - 91, B/P 100/68, T - 98.5;
This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of EPISTAXIS (Nose bleeds almost everyday), LACRIMATION INCREASED (runny eyes), SNEEZING (sneezing), FATIGUE (Fatigue) and MYALGIA (body ache) in a 45-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Allergy to nuts (Anaphylaxis with hazelnut.) and Food allergy (Anaphylaxis with celery.).    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Mar-2021, the patient experienced EPISTAXIS (Nose bleeds almost everyday), LACRIMATION INCREASED (runny eyes) and SNEEZING (sneezing). On 25-Mar-2021, the patient experienced FATIGUE (Fatigue), MYALGIA (body ache) and NAUSEA (nausea). At the time of the report, EPISTAXIS (Nose bleeds almost everyday), LACRIMATION INCREASED (runny eyes) and SNEEZING (sneezing) had not resolved and FATIGUE (Fatigue), MYALGIA (body ache) and NAUSEA (nausea) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  Treatment of the event nose bleeding includes, cauterization of nose.   This case was linked to MOD-2021-107411 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 05-May-2021: Patient demographics,  outcome of events, second dose information with events updated.
"Covid arm." Hot, red, mildly itchy, mildly painful, slightly raised rash on my upper left arm near (but not on) the injection site after the second vaccine.
Chest pain/tightness and shortness of breath started at about 24 hrs. after injection. Chest pain lasted for about 12 hours off and on (not constant). Shortness of breath lasted for about 48 hrs. These were new effects that were not experienced with the first two doses. For all 3 doses, effects were severe - fever, nausea, headache, body aches lasting from 5 hrs. after injection up through about 48 hours after injection. Effects seemed to escalate with each dose. First two doses were in March 2021. Patient is otherwise healthy and had not ever experienced chest pain or shortness of breath before.
3 days post-vaccine I noticed a hive-like rash on my lower right abdomen. Over the course of the next few days it became increasingly itchy - though not painful - and was spreading. I initially thought it was a bug bite of some kind until other similar spots started appearing in the same area. By the weekend following my vaccination (2/12/13) I had an area of red surrounding individual raised bumps and I'd begun to assume it was one of the rashes sometimes associated with the vaccine. By Sunday evening  (2/13) and especially on Monday (2/14), I noticed pain and sensitivity along the rash area which seemed to be continuing it's spread linearly around the side of my abdomen and to a couple of spots in my lower right back. On Tuesday morning (2/15) it suddenly occurred to me what a "linear rash" that was both painful and itchy might be. I made an appointment with the pharmacy clinic and the diagnosis of shingles was confirmed. It was, and remains, a mild case - isolated to the abovementioned area and never more than annoyingly painful.
On 10/24/2022 I had a minor sore throat. I thought it was a sinus infection so, I did the home remedies to get rid of the sore throat. On 10/26/2022 around 02:00AM in the morning I started feeling nausea. I wasn?t sure what was happening with me. In the morning I was feeling extremely tired with loss of appetite. I did a COVID-19 home test which was positive. I contacted my doctor on Wednesday and he prescribed me with Paxlovid for 5 days. As of today 11/02/2022, I am recovering from my symptoms.
This spontaneous report was received from a healthcare worker refers to a multiple unspecified patients of unknown age. On an unknown dates, the patients were vaccinated wit ZOSTAVAX lot # L035286, 15-DEC-2016. No adverse effects were reported. Temperature of 2.8 degree centigrade for 6hours 46 minutes and it was administrated previously there was no temperature excursion. This is one of the 3 reports received from the same reporter. Additional information has been requested.
Fever, body aches, fatigue for about 30 hours.  Pain and stiffness at injection site. Rash at injection site a few days after injection.
This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In March 2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In March 2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered). In March 2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   A group of 11 patients received the first or second dose of Moderna COVID-19 vaccine beyond the expiration date. The patients did not have side effect   Most recent FOLLOW-UP information incorporated above includes: On 25-Mar-2021: A follow up was received which contained no  new information; Sender's Comments: This report refers to a case of Expired Product Administered for mRNA-1273 (Lot #: 025J20-2A)  with no associated AEs.
felt a little sore after the 1st dose; This is a spontaneous report from a Pfizer sponsored program. A contactable consumer (patient) reported a female patient of unspecified age received dose 1 of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) via an unspecified route of administration on 31Mar2021 as a single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. On an unspecified date after dose 1 of BNT162B2 the patient experienced her arm felt a little sore. The outcome of her arm felt a little sore was unknown.  No follow-up attempts are possible; information about batch/lot number cannot be obtained.
Low fever, muscle pain, joint pain, fatigue, mouth sores, "taste of metal"
recent asymptomatic COVID-19 infection coming with shortness of breath. Patient has been experiencing progressively worsening shortness of breath for the past few days. She also endorses associated cough   Date/type of positive COVID test: 6/2/22
Severe Pruritis around the injection site. Pt unconsciously scratched the site then the severe redness and swelling around the injection site started spreading.
Treatment of COVID-19; Treatment of COVID-19; tested positive again; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 41-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 15Dec2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 41 years for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Multiple sclerosis" (unspecified if ongoing); "known allergies: Penicillin" (unspecified if ongoing); "known allergies: sulfa" (unspecified if ongoing). There were no concomitant medications. Past drug history included: Erythromycin, reaction(s): "known allergies: Erythromycin"; Clindamycin, reaction(s): "known allergies: Clindamycin". The following information was reported: DISEASE RECURRENCE (medically significant) with onset 09Aug2022, outcome "not recovered", described as "tested positive again"; DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "recovered" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Positive, notes: COVID 19 Treatment; (02Aug2022) Negative; (03Aug2022) Negative; (04Aug2022) Negative; (05Aug2022) Negative; (06Aug2022) Negative; (07Aug2022) Negative; (08Aug2022) Negative; (09Aug2022) Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Tested positive for Covid; Tested positive for Covid; This is a spontaneous report from a Pfizer sponsored program. A contactable consumer (patient) reported that a female patient of unspecified age received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection and Lot Number: unknown) via an unspecified route of administration on 23Feb2021 as a single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown) on 29Jan2021 at single dose for COVID-19 immunization. Patient stated that she got tested positive 2 times for 3 months. She mentioned that she got the 1st vaccine last 29Jan2021 and got the 2nd dose 23Feb2021 (More than 21 days). She stated that they need to reschedule the date due to bad weather. On the 28Feb2021, the caller was tested positive for Covid. Caller then had another test and was again tested positive. The outcome of the events was unknown.   No follow-up attempts are needed. No further information is expected.
On 24APR91 pt devel fever of 106, jerky movements taken to ER given tepid sponge bath until fever dec; 26APR91 fever inc 106 pt returned to ER; mom told by MD DTP/MMR caused high fever;
he died; This spontaneous case was reported by a consumer and describes the occurrence of DEATH (he died) in a 49-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. Death occurred on 03-Apr-2021 The patient died on 03-Apr-2021. The cause of death was not reported. It is unknown if an autopsy was performed.            No concomitant medications were reported. No treatment medications were reported.  Action taken with mRNA-1273 in response to the event was not applicable.  Very limited information regarding this event has been provided at this time.  Further information has been requested; Sender's Comments: Very limited information regarding this event has been provided at this time.  Further information has been requested; Reported Cause(s) of Death: Unknown cause of death
Swelling of lymph nodes; This spontaneous case was reported by a nurse and describes the occurrence of LYMPHADENOPATHY (Swelling of lymph nodes) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included TRAZODONE, AMLODIPINE BESILATE (NORVASC), OMEPRAZOLE (PROTONIX [OMEPRAZOLE]), GABAPENTIN, LOSARTAN, BUPROPION, FLUOXETINE HYDROCHLORIDE (PROZAC) and LEVOTHYROXINE for an unknown indication.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced LYMPHADENOPATHY (Swelling of lymph nodes). The patient was treated with PREDNISONE at a dose of 20 mg and AMOXICILLIN SODIUM, CLAVULANATE POTASSIUM (AMOXYCILLIN [AMOXICILLIN SODIUM;CLAVULANATE POTASSIUM]) at an unspecified dose and frequency. At the time of the report, LYMPHADENOPATHY (Swelling of lymph nodes) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment information was not provided.
p/vax burning, hives appeared upper arms, chest, face, lips swollen;to ER given pred & DPH;